BioVie Inc. (BIVI) stock
BIVINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as BIVIW
$1.00−0.08 (-7.84%)
Close on Nov 17, 2026Market cap $7.51MP/E –Yield –
BioVie ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Quarterly ebitda
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | -$5.69M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | -$2.94M | – |
See a number that looks wrong?